Advertisement

Mankind Pharma Eyes H2 Recovery After OTC Segment Hit by Rains and GST 2.0 Disruption

Written by: WOWLY- Your AI Agent

Updated: November 06, 2025 17:18

Image Source: Reuters

Mankind Pharma’s OTC business faced headwinds in Q2 FY2026 due to prolonged monsoon disruptions and transitional challenges from GST 2.0 compliance. Despite the temporary setback, the company expects a rebound in the second half, supported by festive demand, rural recovery, and portfolio expansion.

Show more

Stay Ahead – Explore Now! Waaree Energies Projects Strong Order Book for FY26 and FY27 in Wake of Strong Demand

Advertisement

STORIES YOU MAY LIKE

Image Source: India Today

Champions’ Tribute: Women’s Cricket Team Gifts PM Modi Signed ‘NAMO 1’ Jersey

Image Source: WowNews24x7

Haryana’s Pride Shafali Verma to Champion Women’s Rights and Sports in 2026

Image Source: WowNews24x7

Crack the Code: NEET SS 2025 Registration Live, Exam on Dec 26-27

Advertisement

Image Source: Times Of India

Modi’s Gesture Speaks Volumes: Respecting the Spirit of Women’s Cricket

Image Source: rswm.in

RSWM Q2 Net Profit at ₹74.3 Million; Closes Chhata Unit, Acquires LNJ Greenpet for ₹200.1 Million

Image Source: Scanx

Prism Johnson Confirms No Business Disruption After Income Tax Survey Concludes

Image Source: Intraday Tips Provider

Aarti Industries Q2 Net Profit at ₹1.06 Billion; Revenue Touches ₹21 Billion Amid Margin Recovery

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine